An anise polysaccharide, its extraction and purification method, and its application in intervening in Escherichia coli biofilm colonization.

A high-purity anise polysaccharide IVP-3 was successfully obtained through an integrated purification route combining low-temperature water extraction, dual-enzyme synergistic hydrolysis, and two-stage column chromatography. This approach addresses the shortcomings in the extraction and antibacterial activity studies of anise polysaccharides and reveals its intervention effect on Escherichia coli biofilms, demonstrating broad application prospects.

CN123106935APending Publication Date: 2026-11-17GUANGXI UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202610768507.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-05-30
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing research lacks systematic studies on the extraction process and bioactivity of star anise polysaccharides, especially their antibacterial activity.

Method used

An integrated purification route combining low-temperature water extraction, dual-enzyme synergistic hydrolysis, biphasic sequential extraction, and two-stage column chromatography was adopted. The liquid-liquid extraction step of Sevag reagent and petroleum ether was combined with precise fractionation by DEAE anion exchange column and Sephacryl S-400HR gel chromatography column to obtain high-purity star anise polysaccharide IVP-3.

Benefits of technology

The extraction and purification of high-purity star anise polysaccharide were achieved, revealing its comprehensive intervention effect on Escherichia coli biofilm. It has a unique application mechanism and no obvious risk of drug resistance, meets the safety standards of food and medicine homology, and has broad prospects for industrial transformation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123106935A_ABST
    Figure CN123106935A_ABST
Patent Text Reader

Abstract

This invention provides anise polysaccharide, its extraction and purification method, and its application in intervening in Escherichia coli biofilm colonization, belonging to the field of polysaccharide extraction technology. The method includes preparing a crude polysaccharide extract, collecting the upper aqueous phase, collecting the lower aqueous phase, preparing a purified crude polysaccharide, preparing anion-purified polysaccharide, and preparing purified polysaccharide. The step of preparing the ion-purified polysaccharide involves dissolving the purified crude polysaccharide in pure water, centrifuging to obtain the supernatant, purifying it using an anion exchange column, sequentially using pure water and 0.1-0.3M... Gradient elution with NaCl solution, followed by rotary concentration, dialysis, and freeze-drying, yielded ion-purified polysaccharides IVP-1, IVP-2, and IVP-3. IVP-3 was then purified by gel electrophoresis to obtain purified star anise polysaccharide IVP-3. The purified star anise polysaccharide IVP-3 comprises galacturonic acid, arabinose, xylose, galactose, rhamnose, glucuronic acid, glucose, and fucose in a molar ratio of 44.4-44.6:20.2-20.4:16.6-16.8:8.50-8.58:7.5-7.6:1.4-1.5:0.45-0.55:0.4-0.5. The star anise polysaccharide obtained by this invention has high purity and a significant intervention effect on Escherichia coli biofilm.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of polysaccharide extraction technology, specifically relating to an octantrum polysaccharide, its extraction and purification method, and its application in intervening in Escherichia coli biofilm colonization. Background Technology

[0002] Star anise is an aromatic medicinal plant belonging to the genus Illicium in the family Magnoliaceae. Its fruit is similar in shape to a gear and is usually composed of 8 follicles. This plant has many folk names, such as "big anise," "big spice," "five-spice star anise," "aniseed star anise pearl," "imported anise," and "imported anise." As an important medicinal and edible plant in my country, star anise is both a traditional Chinese medicine and a widely used spice, occupying an important position in Guangxi's characteristic medicinal resources.

[0003] Modern pharmacological studies have shown that star anise has multiple biological activities, including anti-inflammatory, antioxidant, insecticidal, antiviral, antibacterial, cardiovascular protective, tumor inhibiting, analgesic, and white blood cell increasing effects. Based on the above-mentioned broad pharmacological activities, star anise shows potential development and application value in the fields of medicine, food, and agriculture.

[0004] To further clarify its active substance basis and mechanism of action, a large number of related studies have been carried out globally, and many discoveries have been made.

[0005] Studies by Pahore AK et al. have found that the methanol extract of star anise has a significant anticancer effect on MCF-7 cells, with mechanisms including cytotoxicity, inhibition of cancer cell proliferation, and induction of cancer cell apoptosis. Research by Mingzhu Liu et al. has shown that star anise extracts (IVAE, IVE, SKA, TAT, DDBA, and QCE) exhibit excellent antiviral activity against SGIV-Gx infection, providing an important foundation for developing effective treatments for severe iridovirus infection in farmed grouper. Preliminary results from Mohammed S Alhajj indicate that star anise extract may be a natural alternative source of antiviral drugs. Furthermore, Hafiz Nadeem Khan discovered that star anise extract has the ability to reduce glycation, hyperglycemia, oxidative stress, and AGE formation (in vitro and in vivo), thus it could be used as an adjunct therapy for diabetes and non-enzymatic glycation reactions. In addition to its medicinal value, star anise fruit and seed extracts are widely used in daily chemical products such as perfumes, toothpaste, soaps, cosmetics, and insect repellents, demonstrating broad application prospects.

[0006] Currently, scholars at home and abroad have conducted relatively systematic research on the small molecule components such as volatile oils, flavonoids and terpenes in star anise, clarifying its various active ingredients and corresponding pharmacological effects. The relevant results have been widely applied. However, compared with the in-depth exploration of the aforementioned small molecule components, the research on polysaccharide components in star anise is significantly lagging behind, and their extraction process, structural characteristics, and bioactivity have not yet been fully elucidated.

[0007] Existing research indicates that plant polysaccharides have multiple functions such as immunomodulation, anti-inflammation, and antibacterial activity. However, systematic research on star anise polysaccharides is still relatively scarce, especially in terms of their antibacterial activity, which has been rarely reported.

[0008] Based on this, in order to make up for the shortcomings of existing research and further expand the medicinal value of star anise, this study focuses on the extraction and purification process of star anise polysaccharides, and focuses on its intervention effect on Escherichia coli biofilm, in order to provide a scientific basis for the in-depth development and clinical application of star anise polysaccharides. Summary of the Invention

[0009] To address the aforementioned shortcomings, this invention provides a method for extracting and purifying star anise polysaccharides, achieving high purity and demonstrating a significant intervention effect on Escherichia coli biofilms.

[0010] This invention is achieved through the following technical solution: An extraction and purification process for star anise polysaccharides includes the following steps: (1) Preparation of crude polysaccharide extract After being crushed and dried, star anise fruit was mixed with pure water at a ratio of 1:3-4 g / mL and extracted at 68-72℃ for 2.0-2.5 h. The extraction was repeated twice to obtain an extract. The extract was then concentrated by rotary evaporation, with the cooling water temperature controlled at 3-5℃, the rotation speed at 50-70 rpm, the water bath temperature at 50-60℃, and the vacuum degree at -0.09~-0.1MPa. Then, 4-6 times the volume of anhydrous ethanol was added, and the mixture was allowed to stand at 3-5℃ for 12-14 h for alcohol precipitation. The mixture was then concentrated again until the mass ratio of star anise fruit to the extract was 1:1. The precipitate was collected and freeze-dried to obtain a crude polysaccharide extract. The crude polysaccharide yield is 7.5-8.0%, and the polysaccharide content is 34.0-34.5%.

[0011] (2) Collect the upper water phase Crude polysaccharide was dissolved in pure water, and papain and complex protease were added. The mixture was hydrolyzed for 15-18 hours to obtain the hydrolysate. Sevag reagent was added to the hydrolysate at a volume ratio of 1:3-4. After thorough mixing, the upper aqueous phase was collected to remove the protein components. The mass-to-volume ratio of the crude polysaccharide, purified water, papain, and complex protease is 30g:780-830mL:0.5-0.6g:0.5-0.6g; The Sevag reagent is a mixture of chloroform and n-butanol, with a volume ratio of chloroform to n-butanol of 3-4:1.

[0012] (3) Collect the lower water phase Petroleum ether was added to the collected upper aqueous phase at a volume ratio of 1:3-4. After thorough mixing, the lower aqueous phase was collected to remove lipid and pigment components.

[0013] (4) Preparation of impurity-free crude polysaccharide The collected lower aqueous phase was dialyzed for 45-50 hours using a dialysis bag with a cutoff of 2800-3200 Da to remove small molecule impurities. After rotary concentration, the condensate temperature was controlled at 3-5℃, the rotation speed at 50-70 rpm, the water bath temperature at 50-60℃, and the vacuum degree at -0.09 to -0.1 MPa. After freeze-drying, the purified crude polysaccharide was obtained with a yield of 65-66%.

[0014] (5) Preparation of ion-purified polysaccharides The crude polysaccharides, after impurity removal, were dissolved in pure water and centrifuged at 800-1200g for 8-13 min. The supernatant was then purified by anion exchange column, eluting sequentially with pure water and 0.1-0.3M NaCl solution at a flow rate of 3.5-4.5 mL / min to achieve purification. The eluent was concentrated by rotary evaporation, with the condenser temperature controlled at 3-5℃, the rotation speed at 50-70 rpm, the water bath temperature at 50-60℃, and the vacuum degree at -0.09~-0.1MPa. The polysaccharides were desalted using a dialysis bag for 45-50 h and then freeze-dried to obtain the purified polysaccharides IVP-1, IVP-2, and IVP-3. The purity of the ion-purified polysaccharides was determined using the sulfuric acid-phenol method. The purities of the ion-purified polysaccharides IVP-1, IVP-2, and IVP-3 were 80-81%, 84.0-84.5%, and 82.7-83.4%, respectively. The mass-to-volume ratio of the purified crude polysaccharide to pure water is 5g:200-250mL; The anion exchange column was purchased from Xi'an Lanxiao Technology New Materials Co., Ltd., with the packing material model being DEAE seplife FF and the column size being 26mm × 400mm.

[0015] (6) Preparation of purified polysaccharides IVP-3, anionic polysaccharide, was added to pure water, centrifuged, and the supernatant was separated and purified by gel chromatography. The supernatant was eluted with pure water at a flow rate of 0.8-1.2 mL / min, and the eluent was collected. The eluent was dialyzed for 45-50 h to remove small molecule components. The mixture was then concentrated by rotary evaporation, with the cooling water temperature controlled at 3-5℃, the rotation speed at 50-70 rpm, the water bath temperature at 50-60℃, and the vacuum degree at -0.09 to -0.1 MPa. After freeze-drying, purified star anise polysaccharide IVP-3 was obtained. The purity of the polysaccharide after gel purification was determined using the sulfuric acid-phenol method. The purity of the purified polysaccharide IVP-3 was 82.0-82.7%. IVP-3 comprises galacturonic acid (Gal-UA), arabinose (Ara), xylose (Xyl), galactose (Gal), rhamnose (Rha), glucuronic acid (Glc-UA), glucose (Glc), and fucose (Fuc) in a molar ratio of 44.52:20.29:16.70:8.53:7.55:1.46:0.50:0.43.

[0016] The mass-to-volume ratio of the ion-purified polysaccharide IVP-3 to pure water is 1g:18-22mL; The gel chromatography column was purchased from GE, the packing material was Sephacryl S-400HR, and the column size was 26mm × 1000mm.

[0017] Compared with the prior art, the present invention has achieved the following beneficial effects: 1. The extraction and purification process is green, efficient, and highly targeted, resulting in polysaccharide components with high purity and uniform structure; This invention addresses the high pectin and pigment content of star anise fruit from the authentic "Gui Shi Wei" variety in Guangxi. An integrated purification route of "low-temperature water extraction - dual-enzyme synergistic hydrolysis - biphasic sequential extraction - two-stage column chromatography" was established. This process effectively preserves the thermosensitive active conformation of polysaccharides through extraction with pure water at a mild temperature of 70℃. The innovative use of papain and a complex protease for combined hydrolysis, along with sequential liquid-liquid extraction using Sevag reagent and petroleum ether, achieves efficient one-stop removal of proteins, lipids, and pigments. Precise fractionation using a subsequent DEAE anion exchange column and Sephacryl S-400HR gel chromatography column yielded a single purified component, IVP-3, with a highly concentrated charge density and exclusion range. This method exhibits good reproducibility, and the obtained product demonstrates high purity as determined by the sulfuric acid-phenol method, providing a uniform and stable material basis for subsequent structural analysis and structure-activity relationship studies. 2. The fine structural features of high-purity star anise polysaccharide IVP-3 were clearly characterized for the first time; This invention utilizes modern spectroscopy and spectroscopic techniques to systematically characterize the purified IVP-3 component, clarifying its monosaccharide composition, glycosidic bond linkage mode, and higher-order conformation of the molecular chain. Unlike existing technologies that only describe the physicochemical properties of crude polysaccharides, the specific structural domains of IVP-3 obtained in this invention are the key basis for its specific anti-biofilm activity, filling the characterization gap of star anise polysaccharides at the molecular structure level. 3. This invention reveals the comprehensive intervention effect of IVP-3 on Escherichia coli biofilm colonization, with a unique application mechanism and no obvious risk of drug resistance. Unlike conventional antibacterial agents that rely on killing airborne bacteria, this invention provides a new application of IVP-3 in intervening in the entire life cycle of Escherichia coli biofilm colonization, formation, maturation and dispersion. 4. The raw materials have significant regional advantages, meet the safety standards for food and medicine homology, and have broad prospects for industrial transformation; The raw material selected for this invention is star anise, one of the "Ten Delicacies of Guangxi" traditional Chinese medicine. Based on the authenticity of this specific production area, the raw material has a higher accumulation of active polysaccharides, ensuring batch stability and high activity of the final product. At the same time, as a nationally recognized food and medicine homology variety, star anise naturally provides IVP-3 with high safety. It has excellent regulatory access advantages and huge market application potential in the fields of developing functional foods for preventing and treating intestinal pathogens, feed additives to replace antibiotics, and coating materials for medical devices that resist biofouling. Attached Figure Description

[0018] Figure 1 Preparation of star anise polysaccharide; Among them, A: IVP-3 polysaccharide preparation flow chart; B: Single factor optimization process experiment (a) extraction temperature (b) solid-liquid ratio (c) extraction time (d) number of extractions; C: Response surface optimization extraction process (a) extraction temperature × solid-liquid ratio (b) extraction temperature × extraction time (c) solid-liquid ratio × extraction time; D: Ion chromatography purification; E: Gel chromatography purification; Figure 2 The diagram shows the primary structure characterization of IVP-3; where A: IVP-3 UV full-wavelength scan; B: Molecular weight analysis (a) absolute molecular weight analysis diagram (b) molecular configuration diagram; C: IVP-3 monosaccharide composition diagram; D: FT-IR spectrum; E: XRD spectrum; F: Congo red experimental curve; G: IVP-3 SEM morphology. Figure 3 Total ion current chromatogram (TIC) of IVP-3 methylated derivatives; where A: chromatogram of hydrogen (NaBH4) reduced sample; B: chromatogram of deuterated (NaBD4) reduced sample; Figure 4The images show nuclear magnetic resonance (NMR) analysis results; where A: one-dimensional proton NMR (¹H NMR); B: one-dimensional carbon NMR (¹³C NMR); C: hydrogen-hydrogen ortho-correlation spectrum (COSY); D: heteronuclear single-quantum carbon-hydrogen correlation spectrum (HSQC); E: hydrogen-hydrogen spatial correlation spectrum (NOESY); F: heteronuclear long-range carbon-hydrogen correlation spectrum (HMBC); G: glycans and polysaccharides of IVP-3. Figure 5 The image shows the antibacterial activity of IVP-3 against planktonic E. coli; where A: time-bactericidal curve; B: effect of co-incubation of IVP-3 and E. coli on cell surface morphology observed by SEM. Figure 6 The study investigated the disruptive effects of IVP-3 on bacterial motility and adhesion structures; A: the effect of IVP-3 on the motility of E. coli; B: transmission electron microscopy with negative staining after co-culturing IVP-3 and E. coli. Figure 7 The diagram illustrates the regulatory effect of IVP-3 on E. coli biofilms. A: Experimental flowchart; B: Effect of IVP-3 on E. coli biofilm formation ability detected by crystal violet staining; C: Effect of IVP-3 on the removal of mature E. coli biofilms detected by crystal violet staining; D: Effect of IVP-3 treatment on the number of viable bacteria within the biofilm during biofilm formation; E: Effect of IVP-3 treatment on the number of viable bacteria within mature biofilms; F: Effect of IVP-3 on biofilm formation structure observed by laser confocal microscopy (CLSM); G: Effect of IVP-3 on the removal structure of mature biofilms observed by laser confocal microscopy (CLSM). Detailed Implementation

[0019] The present invention will be further described in detail below with reference to specific embodiments; it should be emphasized that the following description is merely exemplary and not intended to limit the scope and application of the present invention.

[0020] Example 1 An extraction and purification process for star anise polysaccharides includes the following steps: (1) Preparation of crude polysaccharide extract After being crushed and dried, star anise fruit was mixed with pure water at a ratio of 1:3.5 g / mL and extracted at 70℃ for 2.3 h. The extraction was repeated twice to obtain an extract. The extract was concentrated by rotary evaporation, with the cooling water temperature controlled at 4℃, the rotation speed at 60 rpm, the water bath temperature at 55℃, and the vacuum degree at -0.09 MPa. Then, 5 times the volume of anhydrous ethanol was added, and the mixture was allowed to stand at 4℃ for 12 h for alcohol precipitation. The mixture was concentrated again until the mass ratio of star anise fruit to ethanol was 1:1. The precipitate was collected and freeze-dried to obtain a crude polysaccharide extract. The crude polysaccharide yield was 7.8%, and the polysaccharide content was 34.2%.

[0021] (2) Collect the upper water phase Dissolve 30g of crude polysaccharide in 800mL of pure water, add 0.5g each of papain and complex protease and hydrolyze for 16h to obtain the hydrolysate. Add Sevag reagent to the hydrolysate at a volume ratio of 1:3. After thorough mixing, collect the upper aqueous phase to remove protein components.

[0022] The Sevag reagent is a mixture of chloroform and n-butanol, with a volume ratio of chloroform to n-butanol of 4:1.

[0023] (3) Collect the lower water phase Petroleum ether was added to the collected upper aqueous phase at a volume ratio of 1:3. After thorough mixing, the lower aqueous phase was collected to remove lipid and pigment components.

[0024] (4) Preparation of impurity-free crude polysaccharide The collected lower aqueous phase was dialyzed for 48 hours using a dialysis bag with a cutoff of 3000 Da to remove small molecule impurities. After rotary concentration, the condensate temperature was controlled at 4℃, the rotation speed at 60 rpm, the water bath temperature at 55℃, and the vacuum degree at -0.09 MPa. After freeze-drying, the purified crude polysaccharide was obtained with a yield of 65.8%.

[0025] (5) Preparation of ion-purified polysaccharides 5g of purified crude polysaccharide was dissolved in 200mL of pure water. After centrifugation at 1000g for 10min, the supernatant was collected and purified by anion exchange column. The column was eluted sequentially with pure water and 0.2M NaCl solution at a flow rate of 4mL / min to achieve purification. The eluent was concentrated by rotary evaporation with the cooling water temperature controlled at 4℃, the rotation speed at 60rpm, the water bath temperature at 55℃, and the vacuum degree at -0.09MPa. After desalting using a dialysis bag for 48h, the polysaccharides IVP-1, IVP-2, and IVP-3 were obtained after freeze-drying. The purity of the ion-purified polysaccharides was determined using the sulfuric acid-phenol method. The purities of the ion-purified polysaccharides IVP-1, IVP-2, and IVP-3 were 80.7%, 84.2%, and 83.1%, respectively. The anion exchange column was purchased from Xi'an Lanxiao Technology New Materials Co., Ltd., with the packing material model being DEAE seplife FF and the column size being 26 mm × 400 mm.

[0026] (6) Preparation of purified polysaccharides 1 g of ion-purified polysaccharide IVP-3 was added to 20 mL of pure water, centrifuged, and the supernatant was collected. The supernatant was separated and purified by gel chromatography, and eluted with pure water at a flow rate of 1 mL / min. The eluent was collected and dialyzed with a dialysis bag for 48 h to remove small molecule components. After rotary concentration, the condenser temperature was controlled at 4 °C, the rotation speed at 60 rpm, the water bath temperature at 55 °C, and the vacuum degree at -0.09 MPa. After freeze-drying, purified star anise polysaccharide IVP-3 was obtained. The purity of the polysaccharides after gel purification was determined using the sulfuric acid-phenol method. The purity of the purified star anise polysaccharide IVP-3 was 82.2%. The gel chromatography column was purchased from GE, the packing material was Sephacryl S-400HR, and the column size was 26mm × 1000mm.

[0027] Application performance 1. Extraction and purification process of star anise polysaccharide (IVP-3) 1.1 Optimization of extraction process of crude polysaccharide from star anise Univariate analysis revealed that extraction temperature, material-to-liquid ratio, and extraction time had a more significant impact on polysaccharide yield. Figure 1 B), therefore, these three factors were chosen for response surface methodology (RSM). Figure 1 C, Table 1), validated 17 experimental schemes of RSM design (Tables 2-3). Based on the optimal process parameters predicted by RSM and after correction, the extraction temperature was 70℃, the material-to-liquid ratio was 3.5, the extraction time was 2.3h, and the extraction was performed twice. After three repeated verifications, the polysaccharide yield was 7.08% (Table 4).

[0028] 1.2 Purification process of star anise polysaccharides After further impurity removal from the crude polysaccharide, three components, IVP-1, IVP-2, and IVP-3, were obtained through ion exchange purification. Figure 1 (D), with purities of 80.7%, 84.2%, and 83.1%, respectively; Taking into account both viscosity and yield, IVP-3 was selected for gel chromatography purification. Figure 1 E), by merging the main peaks (tubes 39-47), a more homogeneous IVP-3 component was obtained, with a purity of 82.2% as determined by the test.

[0029]

[0030]

[0031]

[0032]

[0033] 2. Structural characterization of star anise polysaccharide (IVP-3) 2.1 Purity Identification of IVP-3 Ultraviolet full-wavelength scanning revealed ( Figure 2 The IVP-3 sample showed no significant absorption in the wavelength range of 200-300 nm, indicating that the polysaccharide sample contained almost no impurities such as pigments, proteins, and nucleic acids.

[0034] 2.2 IVP-3 Molecular Weight Analysis The molecular weight and conformation of IVP-3 were characterized by gel permeation chromatography-multi-angle laser scattering (GPC-MALS). Figure 2 -B shows that the laser scattering (LS) and differential refractive index (RI) signals exhibit a single symmetrical main peak and are synchronized at 22.00-30.00 min, with no other obvious impurity peaks observed, and the binding mass fraction is close to 100%. This confirms that the IVP-3 prepared in this study has high purity, uniform composition, moderately dispersed molecular weight distribution, and clear molecular conformation, providing a reliable structural basis for subsequent studies on biological activity and structure-activity relationship.

[0035] As shown in Table 5, its number-average molecular weight (Mn) is 24.440 kDa, weight-average molecular weight (Mw) is 35.566 kDa, Z-average molecular weight (Mz) is 49.116 kDa, and polydispersity index (PDI) is 1.455. The slope of the molecular configuration diagram is 0.46 ± 0.01, which is close to the characteristic slope (0.5) of the random coil conformation, indicating that IVP-3 exhibits a random coil conformation in the test solution. The radius of rotation analysis shows that the number-average radius of rotation (Rn) is 19.163 nm, the weight-average radius of rotation (Rw) is 19.253 nm, and the Z-average radius of rotation (Rz) is 22.753 nm, which clarifies its spatial structure in solution.

[0036]

[0037] 2.3 Monosaccharide composition analysis of IVP-3 Figure 2 -C results showed that IVP-3 is mainly composed of eight monosaccharides: galacturonic acid (Gal-UA), arabinose (Ara), xylose (Xyl), galactose (Gal), rhamnose (Rha), glucuronic acid (Glc-UA), glucose (Glc), and fucose (Fuc), with molar proportions of 44.52%, 20.29%, 16.70%, 8.53%, 7.55%, 1.46%, 0.50%, and 0.43%, respectively (see Table 6). Among them, Gal-UA, Ara, and Xyl are the main dominant monosaccharides, with a combined molar proportion of 81.51%.

[0038]

[0039] 2.4 IVP-3 Fourier Transform Infrared Spectroscopy (FT-IR) Analysis The IVP-3 Fourier transform infrared (FT-IR) spectroscopy results show that ( Figure 2 -D), 3421.68cm -1 The strong, broad peak at 2935.04 cm⁻¹ represents the stretching vibration of hydroxyl groups (-OH) between / intramolecularly in the polysaccharide, indicating that the molecule is rich in hydroxyl groups and has strong intermolecular hydrogen bonding, which is consistent with its good water solubility. -1 The absorption peak at 1744.49 cm⁻¹ corresponds to the stretching vibration of CH (CH₂ / CH) on the sugar ring, reflecting the alkyl structure of the polysaccharide skeleton; -1 and 1617.88cm -1 The absorption peaks at 1441.67 and 1419.12 cm⁻¹ represent the stretching vibrations of the ester carbonyl group (-COOCH₃) and the free carboxyl group (-COO⁻), respectively, confirming that the polysaccharide contains both methylated and free galacturonic acid structural units; -1 The absorption peaks at [values ​​missing] are attributed to the CH bending vibration and the symmetric stretching vibration of the carboxyl group (-COO⁻), further confirming the presence of the carboxyl and alkyl structures; [values ​​missing] cm⁻¹. -1 The series of absorption peaks in the region correspond to the stretching vibrations of the COC glycosidic bond and CO in the polysaccharide fingerprint region, reflecting the skeletal structure of the pyranose ring, with the peak at 918.24 cm⁻¹ being the most prominent. -1 and 832.80cm -1 The absorption peaks at 760.74, 636.08, and 535.70 cm⁻¹ suggest the presence of β-type and some α-type glycosidic bonds, reflecting the diversity of glycosidic bond linkages; -1 The low wavenumber absorption peaks at these locations are supplementary signals from out-of-plane vibrations of the sugar ring or from substituents.

[0040] The above structural features indicate that IVP-3 is a polysaccharide rich in pectin domains. Its structure, which is rich in hydroxyl groups, contains both free and methylated galacturonic acid, and has a pyranose ring as its core with diverse glycosidic bonds, provides an important structural basis for its potential antibacterial, anti-inflammatory and intestinal flora regulation activities.

[0041] 2.5 IVP-3 X-ray diffraction (XRD) analysis The X-ray diffraction pattern of IVP-3 shows ( Figure 2 The sample exhibited only a broadened and diffuse diffraction peak at 2θ≈20°, and no sharp characteristic crystallization diffraction signal was observed, indicating that the polysaccharide mainly exists in an amorphous state with extremely low crystallinity.

[0042] 2.6 IVP-3 Congo Red (SAP) Test Analysis The results of Congo Red showed ( Figure 2 -F), as the NaOH concentration increased, the λmax of the IVP-3 and Congo red mixture gradually decreased, and its trend was similar to that of the blank control, suggesting that IVP-3 does not have a triple helix structure.

[0043] 2.7 IVP-3 Scanning Electron Microscopy (SEM) Analysis Scanning electron microscopy (SEM) results show ( Figure 2 At magnifications of 1000x (1K) and 5000x (5K), IVP-3 exhibits a sheet-like morphology with irregularly distributed pore structures on its surface and scattered irregular granular material adhering to the surface.

[0044] 2.8 IVP-3 Methylation Analysis Based on the monosaccharide composition results, gas chromatography-mass spectrometry (GC-MS) was further used to analyze the glycosidic bond linkage of IVP-3. Figure 3 (Table 7) A total of 18 glycosidic bond types were detected, among which the main glycosidic bonds and their relative molar percentages were: 4-Gal(p)-UA (47.09%), 4-Xyl(p) (7.41%), 4-Gal(p) (5.85%), 2,5-Ara(f) (5.50%), and 5-Ara(f) (5.24%). This result is consistent with the monosaccharide composition analysis. Based on this, it is speculated that IVP-3 may be a complex pectin-like polysaccharide with homogalacturon (HG) as the main chain, rhamnogalacturon I (RG-I) as the branched side chain, and containing xylose structural units. Its fine structure needs to be further analyzed by NMR.

[0045]

[0046] 2.9. IVP-3 NMR Analysis The fine structure of IVP-3 was further resolved using NMR (Table 8); the ¹H NMR spectrum (Figure 4A) mainly concentrated in the δ 3.0-5.5 ppm range, with multiple coupling signal peaks detected in the anomeric hydrogen region (δ 4.3-5.4 ppm), and their chemical shifts being δ 4.4, 4.45, 4.46, 4.58, 4.68, 4.85, 4.9, 5.03, 5.13, 5.18, and 5.22, indicating that the polysaccharide contains multiple sugar residues; the non-anomeric hydrogen signals were mainly distributed in the δ 3.1-4.2 ppm region, with some signals overlapping significantly, requiring the combination of COSY (Figure 4C) and HSQC (Figure 4D) spectra to assign the H2-H6 chemical shifts of each sugar residue individually; among them, the strong signal peak near δ 4.71 ppm was a solvent peak, and the signal peaks near δ 3.4 ppm and 3.74 ppm were attributed to the hydrogen signals of O-CH3.

[0047] Multiple signal peaks were also detected in the anomeric carbon region (Figure 4B); combined with the ¹³C NMR spectrum ( Figure 4 B) and HSQC spectrum ( Figure 4 D) The cross-peaks in the anodic region identified the anodic signal pairs (δH / δC) present in the sample as follows: 4.9 / 100.4, 5.03 / 99.51, 4.4 / 101.64, 4.58 / 103.77, 5.13 / 106.95, 5.03 / 107.5, 5.18 / 109.25, 5.22 / 97.63, 4.45 / 102.67, 4.85 / 100.1, 4.68 / 100.7, and 4.46 / 101.77 ppm, which were sequentially labeled as sugar residues A and B. Based on the methylation analysis results, anodic signal characteristics, and literature reports, the structural types of each sugar residue were inferred: sugar residue A is →4)-α-D-GalpA-6-OMe-(1→; B The signals around δ 52.87ppm and 59.87ppm are attributed to the carbon signals of O-CH3. (The following are examples of signals: C → 4)-α-D-GalpA-(1→; D → 4)-β-D-Xylp-(1→; E → 2,5)-α-L-Araf-(1→; F → 5)-α-L-Araf-(1→; G → α-L-Araf-(1→; H → α-D-GalpA-(1→; I → 4-OMe-β-D-Galp-(1→; J → 3,4)-α-D-GalpA-(1→; K → β-L-Rhap-(1→; L → 2,4)-β-D-Xylp-(1→; δ 52.87ppm and δ 59.87ppm are attributed to the carbon signals of O-CH3.)

[0048] Taking sugar residue A as an example, the attribution process is illustrated; its anodic signal δ4.9 / 100.4ppm (H1 / C1) suggests that this residue may be an α-configuration galacturonic acid unit; in the COSY spectrum ( Figure 4 In C), H2 (3.65ppm) was assigned by the cross-peak δ4.9 / 3.65ppm; H3 (3.94ppm), H4 (4.4ppm), and H5 (5.09ppm) were assigned sequentially by the cross-peaks δ3.65 / 3.94ppm, δ3.94 / 4.4ppm, and δ4.4 / 5.09ppm; then, based on the correspondence of hydrogen signals in the HSQC spectrum (Figure 4D), carbon chemical shifts were assigned: C1 100.4ppm, C2 67.77ppm, C3 68.48ppm, C4 78.78ppm, C5 70.56ppm, and C6 170.7ppm; among them, the chemical shifts of C1, C4, and C6 shifted to the lower field, indicating that the residue was substituted at the O-1, O-4, and O-6 positions; combined with methylation analysis and literature data, the structure of sugar residue A was inferred to be →4)-α-D-GalpA-6-OMe-(1→).

[0049] Based on the ¹³C and ¹H chemical shifts of each sugar residue, combined with HMBC ( Figure 4 F) and NOESY ( Figure 4 E) Spectroscopic analysis of the linkage patterns in polysaccharides. HMBC spectroscopy ( Figure 4 F) shows: H1 of residue B and C4 of residue D have a cross-peak at δ5.03 / 76.3ppm; H1 of residue F and C5 of residue E have a cross-peak at δ5.03 / 66.86ppm; C1 of residue F and H5 of residue E have a cross-peak at δ107.5 / 3.83ppm; NOESY spectrum ( Figure 4E) further reveals the spatial proximity relationships between residues: H1 of residue A crosses with its own H4 (δ4.9 / 4.4ppm) and H4 of residue J (δ4.9 / 4.34ppm); H1 of residue B crosses with H4 of residue A (δ5.03 / 4.4ppm), H4 of residue B itself (δ5.03 / 4.33ppm), and H4 of residue D (δ5.03 / 4.07ppm); H1 of residue C crosses with H4 of residue L (δ4.4 / 3.94ppm); H1 of residue E crosses with H3 of residue J (δ5.13 / 3.94ppm); H1 of residue F crosses with H5 of residue E (δ5.13 / 3.94ppm). There are cross-peaks between residues G and F (δ 5.18 / 3.89ppm); residue H1 and residue L (δ 5.22 / 3.37ppm); residue I and residue C (δ 4.45 / 3.7ppm); residue J and residue B (δ 4.85 / 4.33ppm); residue K and residue E (δ 4.68 / 4.11ppm); residue L and residue J (δ 4.46 / 3.94ppm).

[0050] Based on the combined information from one-dimensional and two-dimensional NMR spectra and the results of methylation analysis, the main structural features of IVP-3 are inferred as follows: the main chain is composed of sugar residues such as →4)-α-D-GalpA-6-OMe-(1→, →4)-α-D-GalpA-(1→, →4)-β-D-Galp-(1→ and →3,4)-α-D-GalpA-(1→) linked together; the side chain is mainly composed of α-L-Araf-(1→5)-α-L-Araf-(1→ linked to the O-5 position of the →2,5)-α-L-Araf-(1→ residue, and the entire side chain is further linked to the O-3 position of the →3,4)-α-D-GalpA-(1→ residue (see Figure 4G for a schematic diagram of the structure).

[0051]

[0052] 3. IVP-3 against Escherichia coli ( E. coli The impact of biofilm colonization 3.1 IVP-3 pair E. coli Minimum inhibitory concentration (MIC) The results are shown in Table 9. IVP-3 has the effect of E. coli The MIC value of the clinical strain GXU-23-25-310 was 12.5 mg / mL. E. coliThe MIC value of the standard strain ATCC 25922 is 50 mg / mL, indicating that IVP-3 has a certain antibacterial effect. However, the required drug concentration is relatively high, suggesting that it does not work by directly killing bacteria.

[0053]

[0054] 3.2 IVP-3 Antibody E. coli Activity and its effect on growth kinetics The in vitro antibacterial activity of IVP-3 within 24 h was evaluated using the time-bactericidal curve method. Figure 5 -A results showed that, compared with the control group (Con 0), IVP-3 at concentrations of 1 / 2×MIC and MIC exhibited significant antibacterial effects in the early stage of treatment (within 5 h); while IVP-3 at concentrations of 2×MIC significantly reduced the number of viable bacteria after 8 h of treatment, showing a clear bactericidal effect. The results showed that IVP-3 had good concentration- and time-dependent antibacterial activity in vitro.

[0055] 3.3 The disruptive effect of IVP-3 on cell surface morphology SEM was used to observe the ultrastructure of bacterial surfaces. Figure 5 B) In the control group, the bacterial cells were plump and had smooth, intact surfaces. After IVP-3 treatment, the bacterial cells showed obvious signs of damage, such as shrinkage, depression, and even rupture, and the degree of damage was positively correlated with the drug concentration. This result directly confirms that IVP-3 can directly disrupt the integrity of the surface structure of E. coli cells.

[0056] Bacterial motility is a key virulence factor for invasion and spread in host tissues; after treatment with MIC and 2×MIC concentrations of IVP-3 for 4 h, the diameter of the bacterial motility and spread on semi-solid agar plates was significantly reduced compared with the control group. P <0.01), and showed dose-dependent inhibition ( Figure 6 A) This result suggests that IVP-3 can effectively weaken... E. coli Its ability to move and spread may limit its early colonization and invasion range at the site of infection.

[0057] To directly verify the morphological effects of IVP-3 on adhesion and motility-related structures, TEM negative staining was used to observe the ultrastructural changes of pili and flagella. Figure 6 B); the results showed that the control group E. coliThe bacteria exhibit a typical rod-like shape, with abundant pili (short filamentous structures) and flagella (long filamentous motility structures) uniformly attached to their surface, providing a structural basis for bacterial colonization and biofilm formation. Treatment with IVP-3 at a concentration of 1 / 2×MIC resulted in significant detachment of the pili structures on the bacterial surface, with a marked decrease in pili density in some areas. While some flagella structures remained, their integrity declined. Treatment at the MIC concentration further detached the flagella. When the concentration was increased to 2×MIC, the bacterial surface became smooth and flat, and both pili and flagella almost completely disappeared. These results indicate that IVP-3 can directly disrupt bacteria in a concentration-dependent manner. E. coli The fimbriae and flagellar structures inhibit the adhesion, movement, and colonization abilities mediated by these structures at the source.

[0058] 3.9 IVP-3 E. coli Regulatory role of biofilms Biofilms are crucial barriers for bacteria against the external environment, playing a key role in bacterial adhesion, colonization, and pathogenicity. This study used 0.1% crystal violet staining to evaluate the effects of IVP-3 on biofilm formation and clearance of mature biofilms in *Escherichia coli*. Figure 7 As shown in Figure B, compared with the control group, different concentrations of IVP-3 significantly inhibited biofilm formation. P <0.01); in mature biofilm clearance experiments ( Figure 7 C), 1 / 2×MIC of IVP-3 can significantly remove existing biofilms ( P <0.05), while the scavenging effect was extremely significant at MIC and 2×MIC concentrations ( P <0.01); the viable bacteria count results were consistent with the crystal violet quantitative results ( Figure 7 DE, together confirming that IVP-3 has a dual role: significantly inhibiting biofilm formation and clearing / disrupting mature biofilms; To further visualize the structural changes, laser confocal scanning microscopy (CLSM) combined with DMAO / PI double staining was used to analyze the effect of IVP-3 on the biofilm structure of *E. coli*. Figure 7The control group showed dense and uniformly distributed green fluorescence with only a very small amount of red fluorescence; the three-dimensional view showed that the biofilm was of sufficient thickness and structurally stable. After treatment with 1 / 2×MICIVP-3, the green fluorescence weakened and the red fluorescence increased, and the biofilm thickness decreased. At the MIC concentration, the green fluorescence decreased significantly, and the red fluorescence was enriched in punctate or sheet-like patterns. The biofilm thickness was significantly reduced and the structure was loose. When the concentration was increased to 2×MIC, the green fluorescence almost disappeared, and the red fluorescence became dominant. The three-dimensional structure of the biofilm completely collapsed, leaving only a small number of fragments. The above results indicate that IVP-3 can destroy the three-dimensional structure of biofilms and kill bacteria within the biofilm in a concentration-dependent manner, providing morphological evidence for its dual ability to inhibit and remove biofilms.

[0059] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications or equivalent substitutions made within the spirit and principles of the present invention should be within the protection scope of the present invention.

[0060] The embodiments and methods described in this invention may vary based on the capabilities, experience and preferences of those skilled in the art.

[0061] The fact that the steps of the method are listed in a certain order in this invention does not constitute any limitation on the order of the method steps.

Claims

1. A star anise polysaccharide, characterized in that, The purified star anise polysaccharide IVP-3 comprises galacturonic acid, arabinose, xylose, galactose, rhamnose, glucuronic acid, glucose, and fucose, in a molar ratio of 44.4-44.6:20.2-20.4:16.6-16.8:8.50-8.58:7.5-7.6:1.4-1.5:0.45-0.55:0.4-0.

5.

2. The method for extracting and purifying star anise polysaccharides according to claim 1, characterized in that, This includes preparing crude polysaccharide extract, collecting the upper aqueous phase, collecting the lower aqueous phase, preparing impurity-removed crude polysaccharide, preparing ion-purified polysaccharide, and preparing purified polysaccharide; The step of collecting the upper aqueous phase is as follows: dissolve crude polysaccharide in pure water, add papain and complex protease, enzymatically hydrolyze for 15-18 hours to obtain enzymatic hydrolysate, add Sevag reagent, mix thoroughly and then collect the upper aqueous phase. The steps for preparing ion-purified polysaccharides are as follows: the crude polysaccharide after impurity removal is dissolved in pure water, the supernatant is collected by centrifugation, purified by anion exchange column, and eluted sequentially with pure water and 0.1-0.3M NaCl solution. After rotary concentration, the polysaccharides are desalted using a dialysis bag and freeze-dried to obtain ion-purified polysaccharides IVP-1, IVP-2, and IVP-3.

3. The method for extracting and purifying star anise polysaccharides according to claim 2, characterized in that, The steps for preparing the crude polysaccharide extract are as follows: star anise fruit is pulverized and dried, then mixed with pure water at a material-to-liquid ratio of 1:3-4 g / mL, and extracted at 68-72℃ for 2.0-2.5 h, and extracted twice to obtain an extract; the extract is concentrated by rotary evaporation, then anhydrous ethanol is added, and the mixture is allowed to stand at 3-5℃ for 12-14 h for alcohol precipitation, and then concentrated again until the mass ratio of star anise fruit to the extract is 1:

1. The precipitate is collected, and the precipitate is freeze-dried to obtain the crude polysaccharide extract.

4. The method for extracting and purifying star anise polysaccharides according to claim 2, characterized in that, In the step of collecting the upper aqueous phase, the mass-to-volume ratio of the crude polysaccharide, pure water, papain, and complex protease is 30g:780-830mL:0.5-0.6g:0.5-0.6g; The volume ratio of Sevag reagent to enzymatic hydrolysate is 1:3-4. The reagent is a mixture of chloroform and n-butanol, with a volume ratio of chloroform to n-butanol of 3-4:

1.

5. The method for extracting and purifying star anise polysaccharides according to claim 2, characterized in that, The step of collecting the lower aqueous phase is as follows: petroleum ether is added to the collected upper aqueous phase, with a volume ratio of petroleum ether to upper aqueous phase of 1:3-4. After thorough mixing, the lower aqueous phase is collected to remove lipid and pigment components.

6. The star anise polysaccharide and its extraction and purification method according to claim 1, characterized in that, The step of preparing the impurity-removed polysaccharide is as follows: the collected lower aqueous phase is dialyzed for 45-50 hours using a dialysis bag with a retention capacity of 2800-3200 Da to remove small molecule impurities. After rotary concentration and freeze drying, the impurity-removed crude polysaccharide is obtained.

7. The method for extracting and purifying star anise polysaccharides according to claim 2, characterized in that, In the step of preparing ion-purified polysaccharides, the mass-to-volume ratio of the impurity-removed crude polysaccharide to pure water is 5g:200-250mL.

8. The method for extracting and purifying star anise polysaccharides according to claim 2, characterized in that, The steps for preparing the purified polysaccharide are as follows: IVP-3 is added to pure water, centrifuged to obtain the supernatant, separated and purified by gel chromatography, and eluted with pure water at a flow rate of 0.8-1.2 mL / min. The eluent is collected and dialyzed with a dialysis bag for 45-50 h to remove small molecule components. After rotary concentration and freeze drying, purified star anise polysaccharide IVP-3 is obtained. The mass-to-volume ratio of the ion-purified polysaccharide IVP-3 to pure water is 1g:18-22mL.

9. The application of star anise polysaccharide according to claim 1 in intervening in Escherichia coli biofilm colonization.